Literature DB >> 8932872

Three dimensional staging of breast cancer.

I L Wapnir1, D E Wartenberg, R S Greco.   

Abstract

PURPOSE: Breast cancers are three dimensional solids but very few are spherical. We hypothesized that calculations based on the greatest diameter would not accurately reflect tumor volume and that three dimensional measurements would affect tumor staging.
MATERIALS AND METHODS: 165 invasive carcinomas measuring 2.5 cm or less and having three measured diameters (a > or = b > or = c) noted were evaluated. Tumor volume was calculated using four geometric models: the spherical 4/3 pi (a/2)3, prolate spheroid 4/3 pi (a/2) (c/2)2, oblate spheroid 4/3 pi (a/2)2 (b/2), and ellipsoid 4/3 pi (a/2 x b/2 x c/2). The ellipsoid correctly determined the volume for any tumor shape. All cases were stratified according to the TNM staging system. Differences in mean volume calculated as a sphere and ellipsoid for each tumor subclass were analyzed using Student's T test. The reclassification of tumors by the ellipsoid formula was determined.
RESULTS: Seventy-six (46.1%) had tumors with three different diameters while only six (3.6%) were true spheres having three identical diameters. Mean tumor volume analysis of T1a, T1b, T1c, and T2 tumors demonstrated a statistically significant overestimation of volume when utilizing the sphere formula instead of the ellipsoid formula (p < 0.05). The differences in volume were more dramatic as the diameters increased. A total of 41 tumors were moved into smaller T subclasses including 10 node positive patients.
CONCLUSIONS: Tumor volume analysis demonstrates that use of only the greatest diameter poorly reflects the true volume of a lesion and consistently overestimates volume. The ellipsoid formula accurately calculates volume for these three dimensional tumors and when utilized has significant relevance to staging small invasive breast cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8932872     DOI: 10.1007/bf01807032

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

Review 1.  Prognostic factors and treatment decisions in axillary-node-negative breast cancer.

Authors:  W L McGuire; G M Clark
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

Review 2.  Potential innovations in scheduling of cancer chemotherapy.

Authors:  L Norton; R Day
Journal:  Important Adv Oncol       Date:  1991

3.  Tumor volume, nodal status, and metastasis in breast cancer in women.

Authors:  E N Atkinson; B W Brown; E D Montague
Journal:  J Natl Cancer Inst       Date:  1986-02       Impact factor: 13.506

4.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate.

Authors:  J E McNeal; A A Villers; E A Redwine; F S Freiha; T A Stamey
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

5.  Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts.

Authors:  C Weber; L Merriam; T Koschitzky; F Karp; M Benson; K Forde; P LoGerfo
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

6.  Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

Authors:  M J Silverstein; E D Gierson; J R Waisman; G M Senofsky; W J Colburn; P Gamagami
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis.

Authors:  J D Seidman; L A Schnaper; S C Aisner
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

8.  Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.

Authors:  P P Rosen; S Groshen; D W Kinne; L Norton
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

9.  Growth rates of primary breast cancers.

Authors:  L Heuser; J S Spratt; H C Polk
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

  9 in total
  20 in total

1.  The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.

Authors:  Tamara Utermark; Trisha Rao; Hailing Cheng; Qi Wang; Sang Hyun Lee; Zhigang C Wang; J Dirk Iglehart; Thomas M Roberts; William J Muller; Jean J Zhao
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

2.  Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery.

Authors:  Christoph P Hofstetter; Michael J Nanaszko; Lynn L Mubita; John Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 3.  Electrochemotherapy in head and neck cancer: A review of an emerging cancer treatment.

Authors:  Armando De Virgilio; Massimo Ralli; Lucia Longo; Patrizia Mancini; Giuseppe Attanasio; Francesca Atturo; Marco De Vincentiis; Antonio Greco
Journal:  Oncol Lett       Date:  2018-07-12       Impact factor: 2.967

4.  Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.

Authors:  Judy C Boughey; Florentia Peintinger; Funda Meric-Bernstam; Allison C Perry; Kelly K Hunt; Gildy V Babiera; S E Singletary; Isabelle Bedrosian; Anthony Lucci; Aman U Buzdar; Lajos Pusztai; Henry M Kuerer
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

5.  Bioluminescent monitoring of NIS-mediated (131)I ablative effects in MCF-7 xenografts.

Authors:  Malavika Ghosh; Sanjiv Sam Gambhir; Abhijit De; Kent Nowels; Michael Goris; Irene Wapnir
Journal:  Mol Imaging       Date:  2006 Apr-Jun       Impact factor: 4.488

6.  Reliability of CT-based tumor volumetry after intraarterial chemotherapy in patients with small carcinoma of the oral cavity and the oropharynx.

Authors:  Stefan Rohde; Adorján F Kovács; Joachim Berkefeld; Bernd Turowski
Journal:  Neuroradiology       Date:  2006-04-12       Impact factor: 2.804

7.  Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.

Authors:  Xiangyu Yang; Ewa Mrozek; Maryam Lustberg; Guang Jia; Steffen Sammet; Christina Sammet; Charles Shapiro; Michael V Knopp
Journal:  Magn Reson Imaging       Date:  2012-08-11       Impact factor: 2.546

8.  Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques.

Authors:  Sara Regaño; Fernando Hernanz; Estrella Ortega; Carlos Redondo-Figuero; Manuel Gómez-Fleitas
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  The shape of breast cancer.

Authors:  Brook K Byrd; Venkataramanan Krishnaswamy; Jiang Gui; Timothy Rooney; Rebecca Zuurbier; Kari Rosenkranz; Keith Paulsen; Richard J Barth
Journal:  Breast Cancer Res Treat       Date:  2020-07-12       Impact factor: 4.872

10.  Tumours with PI3K activation are resistant to dietary restriction.

Authors:  Nada Y Kalaany; David M Sabatini
Journal:  Nature       Date:  2009-03-11       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.